Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Current Leases (2020 - 2025)

Historic Current Leases for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Burning Rock Biotech's Current Leases fell 4121.5% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4121.5%. This contributed to the annual value of $3.4 million for FY2024, which is 17680.92% up from last year.
  • Burning Rock Biotech's Current Leases amounted to $2.3 million in Q3 2025, which was down 4121.5% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Current Leases ranged from a high of $25.7 million in Q4 2021 and a low of $1.2 million during Q4 2023
  • In the last 5 years, Burning Rock Biotech's Current Leases had a median value of $4.0 million in 2024 and averaged $5.0 million.
  • In the last 5 years, Burning Rock Biotech's Current Leases surged by 338130.08% in 2021 and then tumbled by 7898.57% in 2022.
  • Over the past 5 years, Burning Rock Biotech's Current Leases (Quarter) stood at $25.7 million in 2021, then tumbled by 78.99% to $5.4 million in 2022, then crashed by 77.48% to $1.2 million in 2023, then soared by 176.81% to $3.4 million in 2024, then plummeted by 30.72% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.7 million for Q2 2025, and $3.1 million during Q1 2025.